欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/6022/001
药品名称Apacross 5 mg/ml powder for dispersion for infusion
活性成分
    • Paclitaxel 5.0 mg/ml
剂型Powder for dispersion for infusion
上市许可持有人Seacross Pharma (Europe) Limited Pod 13 The Old Station House 15a Main Street Blackrock A94 T8P8 Dublin Ireland
参考成员国 - 产品名称Netherlands (NL)
Apacross 5 mg/ml poeder voor dispersie voor infusie
互认成员国 - 产品名称
    • Belgium (BE)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Germany (DE)
      Paclitaxel Albumin Seacross 5 mg/ml Pulver zur Herstellung einer Infusionsdispersion
    • Denmark (DK)
      Apacross
许可日期2025/08/27
最近更新日期2025/09/12
药物ATC编码
    • L01CD01 paclitaxel
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase